NSAID acyl glucuronides and enteropathy

Current Drug Metabolism

Volumn 12, Issue 3, 2011, Pages 245-252

  Boelsterli, Urs A ^a   Ramirez Alcantara, Veronica ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Acyl glucuronide; Diclofenac; Enteropathy; Iso glucuronide; NSAIDs; Small intestinal ulceration

Indexed keywords

ACYL GLUCURONIDE; AGLYCONE; BETA GLUCURONIDASE; GLUCURONIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOPHILE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EXCRETION; DRUG STRUCTURE; DRUG TRANSPORT; ELECTROPHILICITY; ENTEROPATHY; HUMAN; HUMAN CELL; INTESTINE CELL; INTRAHEPATIC BILE DUCT; NONHUMAN; PH; PROTEIN TARGETING; TOXICOKINETICS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GLUCURONIDES; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL;

EID: 79953659282     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920011795101877     Document Type: Article

References (78)

1. Boelsterli, U.A. Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions. Curr. Drug Metab., 2002, 3, 439-450. (Pubitemid 34778006)
2. Bailey, M.J.; Dickinson, R.G. Acyl glucuronide reactivity in perspective: Biological consequences. Chem. Biol. Interact., 2003, 145, 117-137. (Pubitemid 36398426)
3. Skonberg, C.; Olsen, J.; Madsen, K.G.; Hansen, S.H.; Grillo, M.P. Metabolic activation of carboxylic acids. Expert Opin. Drug Metab. Toxicol., 2008, 4, 425-438. (Pubitemid 351728516)
4. Stachulski, A.V. Chemistry and reactivity of acyl glucuronides. Curr. Drug Metab., 2011, 12(2).
5. Asif, A.R.; Armstrong, V.W.; Voland, A.; Wieland, E.; Oellerich, M.; Shipkova, M. Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. Biochimie, 2007, 89, 393-402. (Pubitemid 46436257)
6. Hargus, S.J.; Amouzedeh, H.R.; Pumford, N.R.; Myers, T.G.; McCoy, S.C.; Pohl, L.R. Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac. Chem. Res. Toxicol., 1994, 7, 575-582. (Pubitemid 24232356)
7. Hargus, S.J.; Martin, B.M.; George, J.W.; Pohl, L.R. Covalent modification of rat liver dipeptidyl peptidase IV (CD26) by the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol., 1995, 8, 993-996.
8. Seitz, S.; Boelsterli, U.A. Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology, 1998, 115, 1476-1482. (Pubitemid 28545998)
9. Seitz, S.; Kretz-Rommel, A.; Oude Elferink, R.P.J.; Boelsterli, U.A. Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2). Chem. Res. Toxicol., 1998, 11, 513-519. (Pubitemid 28242496)
10. Dong, J.Q.; Liu, J.; Smith, P.C. Role of benoxaprofen and flunoxaprofen acyl glucuronides in covalent binding to rat plasma and liver proteins in vivo. Biochem. Pharmacol., 2005, 70, 937-948. (Pubitemid 41138859)
11. Ware, J.A.; Graf, M.L.M.; Martin, B.M.; Lustberg, L.R.; Pohl, L.R. Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: possible role in allergic reactions. Chem. Res. Toxicol., 1998, 11, 164-171. (Pubitemid 28141742)
12. Atchison, C.R.; West, A.B.; Balakumaran, A.; Hargus, S.J.; Pohl, L.R.; Daiker, D.H.; Aronson, J.F.; Hoffmann, W.E.; Shipp, B.K.; Moslen, M.T. Drug enterocyte adducts: Possible causal factors for diclofenac enteropathy in rats. Gastroenterology, 2000, 119, 1537-1547. (Pubitemid 32198679)
13. Shipkova, M.; Beck, H.; Voland, A.; Armstrong, V.W.; Grone, H.J.; Oellerich, M.; Wieland, E. Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue. Proteomics, 2004, 4, 2728-2738. (Pubitemid 39202173)
14. Cannell, G.R.; Bailey, M.J.; Dickinson, R.G. Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro. Life Sci., 2002, 71, 2633-2643. (Pubitemid 35279306)
15. Sallustio, B.C.; DeGraaf, Y.C.; Weekley, J.S.; Burcham, P.C. Bioactivation of carboxylic acid compounds by UDP-glucuronosyltransferases to DNA-damaging intermediates: Role of glycoxidation and oxidative stress in genotoxity. Chem. Res. Toxicol., 2006, 19, 683-691. (Pubitemid 43800985)
16. Kenny, J.R.; Maggs, J.L.; Tettey, J.N.A.; Harrell, A.W.; Parker, S.G.; Clarke, S.E.; Park, B.K. Formation and protein binding of the acyl glucuronide of a leukotriene B4 antagonist (SB-209247): Relation to species differences in hepatotoxicity. Drug Metab. Dispos., 2005, 33, 271-281. (Pubitemid 40216595)
17. Cohen, S.D.; Hoivik, D.J.; Khairallah, E.A. Acetaminopheninduced hepatotoxicity. In: Toxicology of the Liver; Plaa, G.L.; Hewitt, W.R., Ed.; Taylor & Francis: Washington, D.C., 1998; pp. 159-186.
18. Sallustio, B.C.; Sabordo, L.; Evans, A.M.; Nation, R.L. Hepatic disposition of electrophilic acyl glucuronide conjugates. Curr. Drug Metab., 2000, 1, 163-180.
19. Lagas, J.S.; Sparidans, R.W.; Wagenaar, E.; Beijnen, J.H.; Schinkel, A.H. Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATPbinding cassette efflux transporters. Mol. Pharmacol., 2010, 77, 687-694.
20. Fortun, P.J.; Hawkey, C.J. Nonsteroidal antiinflammatory drugs and the small intestine. Curr. Opin. Gastroenterol., 2007, 23, 134-141. (Pubitemid 46192967)
21. Hayashi, Y.; Yamamoto, H.; Taguchi, H.; Sunada, K.; Miyata, T.; Yano, T.; Arashiro, M.; Sugano, K. Nonsteroidal anti-inflammatory drug-induced small-bowel lesions identified by double-balloon endoscopy: Endoscopic features of the lesions and endoscopic treatments for diaphragm disease. J. Gastroenterol., 2009, 44(Suppl. XIX), 57-63.
22. Higuchi, K.; Umegaki, E.; Watanabe, T.; Yoda, Y.; Morita, E.; Murano, M.; Tokioka, S.; Arakawa, T. Present status and strategy of NSAIDs-induced small bowel injury. J. Gastroenterol., 2009, 44, 879-888.
23. Adebayo, D.; Bjarnason, I. Is nonsteroidal anti-inflammatory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad. Med. J., 2006, 82, 186-191.
24. Lanas, A. Nonsteroidal anti-inflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: A trip from peptic ulcer to colon cancer. Am. J. Med. Sci., 2009, 338, 96-106.
25. Tanaka, A.; Hase, S.; Miyazawa, T.; Takeuchi, K. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: A key to nonsteroidal anti-inflammatory drug-induced intestinal damage. J. Pharmacol. Exp. Ther, 2002, 300, 754-761. (Pubitemid 34164976)
26. Adler, D.H.; Phillips, J.A.; Cogan, J.D.; Iverson, T.M.; Schnetz- Boutaud, N.; Stein, J.A.; Brenner, D.A.; Milne, G.L.; Morrow, J.D.; Boutaud, O.; Oates, J.A. The enteropathy of prostaglandin deficiency. J. Gastroenterol., 2009, 44(Suppl. XIX), 1-7.
27. Whittle, B.J.R. Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors. Eur. J. Pharmacol., 2004, 500, 427-439. (Pubitemid 39304025)
28. Somasundaram, S.; Rafi, S.; Hayllar, J.; Sigthorsson, G.; Jacob, M.; Price, A.B.; Macpherson, A.; Mahmod, T.; Scott, D.; Wrigglesworth, J.M.; Bjarnason, I. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut, 1997, 41, 344-353. (Pubitemid 27428194)
29. Somasundaram, S.; Sigthorsson, G.; Simpson, R.J.; Watts, J.; Jacob, M.; Tavares, I.A.; Rafi, S.; Roseth, A.; Foster, R.; Price, A.B.; Wrigglesworth, J.M.; Bjarnason, I. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment. Pharmacol. Ther., 2000, 14, 639-650. (Pubitemid 30240758)
30. Watanabe, T.; Higuchi, K.; Kobata, A.; Nishio, H.; Tanigawa, T.; Shiba, M.; Tominaga, K.; Fujiwara, J.; Oshitani, N.; Asahara, T.; Nomoto, K.; Takeuchi, K.; Arakawa, T. Non-steroidal antiinflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut, 2008, 57, 181-187. (Pubitemid 351158044)
31. Treinen-Moslen, M.; Kanz, M.F. Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road. Pharmacol. Ther., 2006, 112, 649-667. (Pubitemid 44596214)
32. Wax, J.; Clinger, W.A.; Varner, P.; Bass, P.; Winder, C.V. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology, 1970, 58, 772-780.
33. Sawamura, R.; Okudaira, N.; Watanabe, K.; Murai, T.; Kobayashi, Y.; Tachibana, M.; Ohnuki, T.; Masuda, K.; Honma, H.; Kurihara, A.; Okazaki, O. Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide. Drug Metab. Dispos., 2010, 38, 1857-1864.
34. Dickinson, R.G. Iso-glucuronides. Curr. Drug Metab., 2011, 12(2)
35. Kretz-Rommel, A.; Boelsterli, U. Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to acute cell injury in cultured rat hepatocytes. Toxicol. Appl. Pharmacol., 1993, 120, 155-161. (Pubitemid 23156384)
36. Lim, M.S.; Lim, P.L.K.; Gupta, R.; Boelsterli, U.A. Critical role of free cytosolic calcium, but not uncoupling, in mitochondrial permeability transition and cell death induced by diclofenac oxidative metabolites in immortalized human hepatocytes. Toxicol. Appl. Pharmacol, 2006, 217, 322-331. (Pubitemid 44855823)
37. Bruyere, A.; Decleves, X.; Bouzom, F.; Proust, L.; Martinet, M.; Walther, B.; Parmentier, Y. Development of an optimized procedure for the preparation of rat intestinal microsomes: Comparison of hepatic and intestinal microsomal cytochrome P450 enzyme activities in two rat strains. Xenobiotica, 2009, 39, 22-32.
38. Boelsterli, U.A. Reactive acyl glucuronides: Possible role in small intestinal toxicity induced by nonsteroidal anti-inflammatory drugs. Toxic. Subst. Mech., 1999, 18, 83-100. (Pubitemid 29165261)
39. Kaminsky, L.S.; Zhang, Q.Y. The small intestine as a xenobioticmetabolizing organ. Drug Metab. Dispos., 2003, 31, 1520-1525.
40. Kumar, S.; Samuel, K.; Subramanian, R.; Braun, M.P.; Stearns, R.A.; Chiu, S.H.L.; Evans, D.C.; Baillie, T.A. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: Role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. J. Pharmacol. Exp. Ther, 2002, 303, 969-978. (Pubitemid 35424378)
41. Reuter, B.K.; Cirino, G.; Wallace, J.L. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci., 1994, 55, PL1-PL8. (Pubitemid 24185770)
42. Li, L.; Rossoni, G.; Sparatore, A.; Lee, L.C.; Del Sodato, P.; Moore, P.K. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic. Biol. Med., 2007, 42, 706-719. (Pubitemid 46205152)
43. Wallace, J.L.; Caliendo, G.; Santagada, V.; Cirino, G.; Fiorucci, S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology, 2007, 132, 261-271. (Pubitemid 46108763)
44. Jacob, M.; Foster, R.; Sigthorsson, G.; Simpson, R.; Bjarnason, I. Role of bile in pathogenesis of indomethacin-induced enteropathy. Arch. Toxicol., 2007, 81, 291-298. (Pubitemid 46434776)
45. Brodie, D.A.; Cook, P.G.; Bauer, B.J.; Dagle, G.E. Indomethacininduced intestinal lesions in the rat. Toxicol. Appl. Pharmacol., 1970, 17, 615-624.
46. Sallustio, B.C.; Holbrook, F.L. In vivo perturbation of rat hepatocyte canalicular membrane function by diclofenac. Drug Metab. Dispos., 2001, 29, 1535-1538. (Pubitemid 33111585)
47. Jones, J.A.; Kaphalia, L.; Treinen-Moslen, M.; Liebler, D.C. Proteomic characterization of metabolites, protein adducts, and biliary proteins in rats exposed to 1,1-dichloroethylene or diclofenac. Chem. Res. Toxicol., 2003, 16, 1306-1317. (Pubitemid 37315220)
48. Cowburn, A.S.; Sobolewski, A.; Reed, B.J.; Deighton, J.; Murray, J.; Cadwallader, K.A.; Bradley, J.R.; Chilvers, E.R. Aminopeptidase N (CD13) regulates tumor necrosis factor-α-induced apoptosis in human neutrophils. J. Biol. Chem., 2006, 281, 12458-12467. (Pubitemid 43855332)
49. Ramirez-Alcantara, V.; LoGuidice, A.; Boelsterli, U.A. Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy. Am. J. Physiol. (Gastrointest. Liver Physiol.), 2009, 297, G990-G998.
50. DeSesso, J.M.; Jacobson, C.F. Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem. Toxicol., 2001, 39, 209-228.
51. Ebner, T.; Heinzel, G.; Prox, A.; Beschke, K.; Wachsmuth, H. Disposition and chemical stability of telmisartan 1-Oacylglucuronide. Drug Metab. Dispos., 1999, 27, 1143-1149. (Pubitemid 29463600)
52. Benet, L.Z.; Spahn-Langguth, H.; Iwakawa, S.; Volland, C.; Mizuma, T.; Mayer, S.; Mutschler, E.; Lin, E.T. Predictability of the covalent binding of acidic drugs in man. Life Sci., 1993, 53, PL141-PL146.
53. King, A.R.; Dickinson, R.G. The utility of the bile-exteriorized rat as a source of reactive acyl glucuronides: studies with zomepirac. J. Pharmacol. Toxicol. Meth., 1996, 36, 131-136. (Pubitemid 26427000)
54. Borgström, B.; Dahlqvist, A.; Lundh, G.; Sjövall, J. Studies of intestinal digestion and absorption in the human. J. Clin. Invest., 1957, 36, 1521-1536.
55. Ovesen, L.; Bendtsen, F.; Tage-Jensen, U.; Pedersen, N.T.; Gram, B.R.; Rune, S.J. Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology, 1986, 90, 958-962. (Pubitemid 16124773)
56. Evans, D.F.; Pye, G.; Bramley, R.; Clark, A.G.; Dyson, T.J.; Hardcastle, J.D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 1988, 29, 1035-1041.
57. Gorbach, S.L.; Plaut, A.G.; Nahas, L.; Weinstein, L.; Spanknebel, G.; Levitan, R. Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology, 1967, 53, 856-867.
58. Kent, T.H.; Cardelli, R.M.; Stamler, F.W. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am. J. Pathol., 1969, 54, 237-248.
59. Robert, A.; Asano, T. Resistance of germfree rats to indomethacininduced intestinal lesions. Prostaglandins, 1977, 14, 333-341. (Pubitemid 8171147)
60. Uejima, M.; Kinouchi, T.; Kataoka, K.; Hiraoka, I.; Ohnishi, Y. Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. Microbiol. Immunol., 1996, 40, 553-560. (Pubitemid 26282108)
61. Lanas, A.; Scarpignato, C. Microbial flora in NSAID-induced intestinal damage: A role for antibiotics? Digestion, 2006, 73(suppl. 1), 136-150.
62. Dickinson, R.G.; King, A.R. Rearrangement of diflunisal acyl glucuronide into its β-glucuronidase-resistant isomers facilitates transport through the small intestine to the colon of the rat. Life Sci., 2001, 70, 25-36. (Pubitemid 33124354)
63. Schwer, H.; Langmann, T.; Daig, R.; Becker, A.; Aslanidis, C.; Schmitz, G. Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem. Biophys. Res. Commun., 1997, 233, 117-120. (Pubitemid 27215920)
64. Grillo, M.P.; Knutson, C.G.; Sanders, P.E.; Waldon, D.J.; Hua, F.; Ware, J.A. Studies on the chemical reactivity of diclofenac acyl glucuronide with glutathione: Identification of diclofenac-S-acylglutathione in rat bile. Drug Metab. Dispos., 2003, 31, 1327-1336. (Pubitemid 37310321)
65. Grillo, M.P.; Hua, F.; Knutson, C.G.; Ware, J.A.; Li, C. Mechanistic studies on the bioactivation of diclofenac: Identification of diclofenac- S-acyl-glutathione in vitro in incubations with rat and human hepatocytes. Chem. Res. Toxicol., 2003, 16, 1410-1417. (Pubitemid 37464462)
66. Grillo, M.P. Drug S-acyl glutathione thioesters: Chemical synthesis, bioanalytical properties, chemical reactivity, and biological formation and degradation. Curr. Drug Metab., 2011, 12(2)
67. Grillo, M.P.; Hua, F.; March, K.L.; Benet, L.Z.; Knutson, C.G.; Ware, J.A. γ-Glutamyltranspeptidase-mediated degradation of diclofenac-S-acyl- glutathione in vitro and in vivo in rat. Chem. Res. Toxicol., 2008, 21, 1933-1938.
68. Sigthorsson, G.; Simpson, R.J.; Walley, M.; Anthony, A.; Foster, R.; Hotz-Behoftsitz, C.; Palizban, A.; Pombo, J.; Watts, J.; Morham, S.G.; Bjarnason, I. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology, 2002, 122, 1913-1923. (Pubitemid 34651435)
69. Tanaka, A.; Hase, S.; Miyazawa, T.; Ohno, R.; Takeuchi, K. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: Relation to various pathogenic events. J. Pharmacol. Exp. Ther., 2002, 303, 1248-1254. (Pubitemid 35424411)
70. Fujimori, S.; Tsuguhiko, S.; Gudis, K.; Ehara, A.; Kobayashi, T.; Mitsui, K.; Yonezawa, M.; Tanaka, S.; Tatsuguchi, A.; Sakamoto, C. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: A pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest. Endosc., 2009, 69, 1339-1346.
71. Bjarnason, I.; Hallyar, J. Early pathogenetic events in NSAIDinduced gastrointestinal damage. Ital. J. Gastroenterol. Hepatol., 1996, 28(Suppl. 4), 19-22. (Pubitemid 27055710)
72. Lane, M.E.; Kim, M.J. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. J. Pharm. Pharmacol., 2006, 58, 1295-1304. (Pubitemid 44580559)
73. Eeckhoudt, S.; Evrard, P.A.; Verbeeck, R.K. Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat. Drug Metab. Dispos., 1997, 25, 428-430. (Pubitemid 27209366)
74. Priymenko, N.; Garnier, F.; Ferre, J.P.; Delatour, P.; Toutain, P.L. Enantioselectivity of the enterohepatic recycling of carprofen in the dog. Drug Metab. Dispos., 1998, 26, 170-6. (Pubitemid 28104085)
75. Boelsterli, U.A. Mechanisms underlying the hepatotoxicity of nonsteroidal anti-inflammatory drugs. In: Drug-induced Liver Disease; Kaplowitz, N.; DeLeve, L., Ed.; Marcel Dekker: New York, NY, 2003; pp. 345-375.
76. LoGuidice, A.; Ramirez-Alcantara, V.; Proli, A.; Gavillet, B.; Boelsterli, U.A. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice. Toxicol. Sci., 2010, 118, 276-285.
77. Geddes, K.; Philpot, D.J. A new role for intestinal alkaline phosphatase in gut barrier maintenance. Gastroenterology, 2008, 135, 8-12. (Pubitemid 351899043)
78. Fiorucci, S. Prevention of nonsteroidal anti-inflammatory druginduced ulcer: Looking to the future. Gastroenterol. Clin. N. Am., 2009, 38, 315-332.